Table 5.
Top 10 most cited references of publications in CVDs and COVID-19 research.
| Rank | Article title | Frequency | BC | Reference |
|---|---|---|---|---|
| 1 | Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study | 523 | 0.16 | (43) |
| 2 | Clinical characteristics of coronavirus disease 2019 in China | 373 | 0.03 | (44) |
| 3 | Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China | 344 | 0.03 | (45) |
| 4 | Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) | 284 | 0.04 | (20) |
| 5 | Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China | 278 | 0.02 | (46) |
| 6 | Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China summary of a report of 72 314 cases from the Chinese center for disease control and prevention | 261 | 0.00 | (47) |
| 7 | Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study | 236 | 0.01 | (48) |
| 8 | SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor | 231 | 0.03 | (49) |
| 9 | Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study | 206 | 0.01 | (50) |
| 10 | COVID-19 and the cardiovascular system | 191 | 0.00 | (51) |
BC, Betweenness Centrality.